Celltrion, Inc.
A biopharma pioneer developing biosimilars and novel drugs for immunology and oncology.
068270 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 인천광역시 연수구 아카데미로 23, 인천광역시
- Website:
- https://www.celltrion.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Celltrion, Inc. is a leading global biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of innovative therapeutics. A pioneer in the biosimilar field, Celltrion launched the world's first monoclonal antibody biosimilar and continues to be a market leader. The company's portfolio includes a range of biosimilars and novel drugs targeting therapeutic areas such as immunology, oncology, hematology, and endocrinology. Celltrion provides comprehensive, end-to-end solutions across the biopharmaceutical value chain, from R&D and clinical trials to production and sales, with a commitment to improving worldwide patient access to high-quality, affordable medicines.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-18 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 724.1 KB | ||
| 2025-09-17 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식취득결정)
|
Korean | 33.3 KB | ||
| 2025-09-08 00:00 |
Related Party Transaction
임원ㆍ주요주주특정증권등거래계획보고서
|
Korean | 70.7 KB | ||
| 2025-09-05 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 26.0 KB | ||
| 2025-09-02 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 28.5 KB | ||
| 2025-09-01 00:00 |
Legal Proceedings Report
투자판단관련주요경영사항 (CTP44(다잘렉스 바이오시밀러) 유럽 임상 3상 시험계획 승인(Part2))
|
Korean | 12.2 KB | ||
| 2025-09-01 00:00 |
Major Shareholding Notification
대규모기업집단현황공시[분기별공시(개별회사용)]
|
Korean | 31.0 KB | ||
| 2025-08-27 00:00 |
Regulatory News Service
풍문또는보도에대한해명(미확정)
|
Korean | 7.9 KB | ||
| 2025-08-25 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 28.5 KB | ||
| 2025-08-19 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 747.4 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 5.6 MB | ||
| 2025-08-14 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 28.5 KB | ||
| 2025-08-13 00:00 |
Regulatory News Service
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
|
Korean | 11.0 KB | ||
| 2025-08-13 00:00 |
Transaction in Own Shares
자기주식취득결과보고서
|
Korean | 28.3 KB | ||
| 2025-08-07 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 26.8 KB |
Automate Your Workflow. Get a real-time feed of all Celltrion, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Celltrion, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
